Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology (NCT04988009)

🧪 Interventions in This Study

• Electronic Health Record Review (OTHER)
• Survey Administration (OTHER)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• M D Anderson Cancer Center — Houston, Texas

📞 Contact the Study Coordinator

Phone: (713) 794-4380

Email: bjobrien@mdanderson.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Central Nervous System Neoplasm

• Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia — Birmingham, Alabama
• Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System — Portland, Oregon
• Cerebrospinal Fluid Biomarkers for Brain Tumors — Rochester, Minnesota

Explore by condition: All Central Nervous System Neoplasm clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.